CRISIL Limited (BOM:500092)

India flag India · Delayed Price · Currency is INR
4,785.40
+34.15 (0.72%)
At close: Apr 24, 2025
15.53%
Market Cap 330.89B
Revenue (ttm) 32.60B
Net Income (ttm) 6.84B
Shares Out n/a
EPS (ttm) 93.55
PE Ratio 48.37
Forward PE n/a
Dividend 49.00 (1.02%)
Ex-Dividend Date Apr 11, 2025
Volume 715
Average Volume 2,763
Open 4,657.00
Previous Close 4,751.25
Day's Range 4,657.00 - 4,822.55
52-Week Range 3,880.75 - 6,955.40
Beta n/a
RSI 52.22
Earnings Date Apr 17, 2025

About CRISIL

CRISIL Limited, an analytical company, together with its subsidiaries, provides ratings, data, research, and analytics and solutions in India, Europe, North America, and internationally. It operates through two segment, Rating Services; and Research, Analytics, and Solutions. The company offers credit ratings for corporates, banks, and bank loans; credit analysis services; grading services; and analytical services. It also provides research and risk solutions, industry reports, customized research assignments, subscription to data services, ind... [Read more]

Industry Credit Reporting Services
Founded 1987
Employees 4,666
Stock Exchange Bombay Stock Exchange
Ticker Symbol 500092
Full Company Profile

Financial Performance

In 2024, CRISIL's revenue was 32.60 billion, an increase of 3.83% compared to the previous year's 31.40 billion. Earnings were 6.84 billion, an increase of 3.89%.

Financial Statements

News

Crisil shares drop over 8% as Q3 revenue declines

Crisil Limited, a subsidiary of S&P Global, faced a sharp decline in its stock price, dropping over 8% after reporting a slight dip in Q3 FY25 revenue. Despite strong profitability growth, investor se...

2 months ago - Business Upturn

Crisil Q3 Results: Revenue down 0.5% to Rs 912.91 crore, Net Profit up 7.03% YoY

Crisil Limited, a subsidiary of S&P Global, has announced its audited financial results for Q3 FY25, reflecting a mixed performance across its revenue and profitability metrics. Key Financial Highligh...

2 months ago - Business Upturn

Top gainers today: Piramal Pharma surges 5.85%, CRISIL rises 3.63%, Aditya Birla Capital gains 2.76%, AstraZeneca Pharma up 2.57%

At 12:53 PM, the stock market witnessed notable gains across several stocks. Here’s a look at the top performers: Piramal Pharma Limited (PPL Pharma): The stock climbed 5.85%, trading at ₹234.20. CRIS...

3 months ago - Business Upturn

CRISIL invests Rs 33.25 Crore in online PSB Loans

CRISIL Limited has announced an investment of ₹33.25 crore to acquire a 4.08% post-money, fully diluted stake in Online PSB Loans Limited (OPL). This strategic move was approved during a board meeting...

4 months ago - Business Upturn